These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3267)

  • 21. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of dopaminergic agonists on motor function.
    Costall B; Naylor RJ
    Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral effects of substance P in rats.
    Barbeau A; Rondeau DB; Jolicoeur FB
    Int J Neurol; 1980; 14(2-4):239-52. PubMed ID: 6194134
    [No Abstract]   [Full Text] [Related]  

  • 25. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 26. 1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.
    Bonta IL; De Vos CJ; Grijsen H; Hillen FC; Noach EL; Sim AW
    Br J Pharmacol; 1971 Nov; 43(3):514-35. PubMed ID: 5157720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.
    Eibergen RD; Carlson KR
    Psychopharmacology (Berl); 1976 Jul; 48(2):139-46. PubMed ID: 826925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats.
    Kelly PH
    Brain Res; 1975 Dec; 100(1):163-9. PubMed ID: 1237342
    [No Abstract]   [Full Text] [Related]  

  • 30. 3 methoxytyramine: a possible endogenous toxin of psychosis?
    Dill RE; Campbell KM
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):975-82. PubMed ID: 4202534
    [No Abstract]   [Full Text] [Related]  

  • 31. Behavioral implications of dopaminergic neurons in the mesolimbic system.
    Iversen SD; Koob GF
    Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
    [No Abstract]   [Full Text] [Related]  

  • 32. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release.
    Peris J; Decambre N; Coleman-Hardee ML; Simpkins JW
    Brain Res; 1991 Dec; 566(1-2):255-64. PubMed ID: 1814541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
    Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
    Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
    Johnson KM
    Fed Proc; 1983 Jun; 42(9):2579-83. PubMed ID: 6133782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
    Cauli O; Pinna A; Valentini V; Morelli M
    Neuropsychopharmacology; 2003 Oct; 28(10):1752-9. PubMed ID: 12865902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mescaline and other o-methylated beta-phenylethylamines: intrastriatal induction of tremor in rats.
    Little MD; Dill RE
    Brain Res; 1969 Apr; 13(2):360-6. PubMed ID: 5772426
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral factors in the mediation of the effects of L-dopa on locomotor activity.
    Butcher LL; Engel J
    J Pharm Pharmacol; 1969 Sep; 21(9):614-6. PubMed ID: 4390341
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphine-induced rotation (circling behavior) in rats and mice: species differences, persistence of withdrawal-induced rotation and antagonism by naloxone.
    Morihisa JM; Glick SK
    Brain Res; 1977 Mar; 123(1):180-7. PubMed ID: 843917
    [No Abstract]   [Full Text] [Related]  

  • 40. A potential anti-parkinson drug, N-n-propyl-N-n-butyl-beta-(3,4-dihydroxyphenyl)ethylamine hydrochloride, and its effects in intact and nigra-lesioned rats.
    Ginos JZ; Brown FC
    J Med Chem; 1978 Feb; 21(2):155-60. PubMed ID: 563918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.